Patent holdings for IPC class C07D 281/10

Total number of patents in this class: 149

10-year publication summary

6
2
11
11
17
22
12
10
10
5
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Albireo AB
172
33
Elobix AB
17
15
Glaxosmithkline Intellectual Property (no.2) Limited
312
9
RyCarma Therapeutics, Inc.
26
9
Armgo Pharma, Inc.
12
7
Shire Human Genetic Therapies, Inc.
190
7
Glaxosmithkline Intellectual Property Development Limited
784
6
Assembly Biosciences, Inc.
105
3
HK Inno.n Corporation
126
3
VALO Health, Inc.
196
3
Glaxosmithkline LLC
524
2
Merck Sharp & Dohme Corp.
2183
2
Assia Chemical Industries Ltd.
242
2
Les Laboratoires Servier
496
2
Shanghai Institute of Pharmaceutical Industry
126
2
Shanghai Zhongze Therapeutics, Co. Ltd.
6
2
Hainan Jin Rui Pharmaceutical Co., Ltd.
8
2
Novartis AG
10170
1
F. Hoffmann-La Roche AG
7795
1
Hoffmann-La Roche Inc.
3864
1
Other owners 37